Petra Hirsova, PharmD, PhD
Petra Hirsova, PharmD, PhD is an Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic Rochester, MN. Dr. Hirsova received doctoral training from Charles University, Czech Republic, and Yale University, Connecticut. Subsequently, she became a postdoctoral fellow at Mayo Clinic, where she later rose to the rank of Assistant Professor. She currently leads an independent research program focused on nonalcoholic fatty liver disease (NAFLD), especially as it relates to understanding the pathogenic mechanisms underlying the disease onset and progression, identifying druggable targets, and developing novel therapeutic strategies. Her research program has been supported by multiple funding mechanisms provided by the National Institute of Health (NIH), foundations, and the Mayo Clinic.
Dr. Hirsova serves as an editorial board member for HEPATOLOGY, the official journal of the American Association for the Study of Liver Diseases (AASLD). Dr. Hirsova has also held various leadership positions within the AASLD. She served as a member of the Inclusion and Diversity Committee. Currently, she serves on the steering committee of the NAFLD Special Interest Group (SIG), where she is responsible for educational activities and the steering committee of Liver Cell Biology SIG. Dr. Hirsova has served as a member of the AASLD Abstract Committee for NAFLD research since 2021. In addition, she is a member of the AASLD Research Award Committee. Outside of the AASLD, Dr. Hirsova reviews grants for Charles University, European Science Foundation, and NIH.